Clinical trial
Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)
NCT00431145 · Ludwig-Maximilians - University of Munich, Other · Unknown status
Key facts
| NCT number | NCT00431145 |
|---|---|
| Title | Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD) |
| Official title | Influence of Combined Therapy of Niacin and Statins on Stem Cell Mobilization and Inflammatory Parameters in Patients Suffering From Coronary Artery Disease - Randomized Clinical Study - |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Niacin, Niacin+Statin |
| Enrollment | 80 |
| Start date | Oct 1, 2006 |
| First posted | Feb 5, 2007 |
| Last update posted | Feb 5, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: